Table 1 Characteristic of Study Samples
All Patients | ΔFEV1 > 0.0 L | ΔFEV1 ≥ 0.2 L | ΔFVC > 0.0 L | Pre-FEV1 > 80% Pre-FVC > 80% | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
N | 1637 | 1040 | 213 | 928 | 462 | |||||
Age* | 59.7 | (16.2) | 59.2 | (16.2) | 55.9 | (16.9) | 59.3 | (16.4) | 55.1 | (17.4) |
Male sex | 787 | (48.1%) | 503 | (48.4%) | 141 | (66.2%) | 452 | (48.7%) | 182 | (39.4%) |
Race | ||||||||||
Hispanic | 814 | (49.7%) | 510 | (49.0%) | 99 | (46.5%) | 264 | (28.5%) | 218 | (47.2%) |
White | 475 | (29.0%) | 308 | (29.6%) | 76 | (35.7%) | 464 | (50.0%) | 143 | (31.0%) |
Black | 312 | (19.1%) | 197 | (18.9%) | 35 | (16.4%) | 180 | (19.4%) | 94 | (20.4%) |
Other | 36 | (2.2%) | 25 | (2.4%) | 3 | (1.4%) | 20 | (2.2%) | 7 | (1.5%) |
FEV1, L* | 1.9 | (0.8) | 1.9 | (0.8) | 2.3 | (0.9) | 1.9 | (0.8) | 2.7 | (0.8) |
FVC, L* | 2.8 | (1.1) | 2.8 | (1.1) | 3.4 | (1.2) | 2.7 | (1.0) | 3.5 | (1.0) |
FEV1/FVC%* | 69.1 | (14.5) | 68.8 | (14.6) | 66.8 | (13.2) | 68.6 | (15.0) | 76.8 | (7.6) |